SPOP and ovarian clear cell cancer: In addition, WES showed that it harbors concurrent ARID1A–PIK3CA mutations and SPOP mutation, also with ZNF217 amplification, which will be an ideal tool for mechanism research of ovarian clear cell carcinoma.